Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria France Germany Italy Poland Spain
  • Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria France Germany The Netherlands Poland +1
  • Study of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland
  • Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Denmark Germany Greece Italy Poland +3
  • Study on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Greece +4
  • Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Drugs:
    Bulgaria France Germany Greece The Netherlands Poland +1
  • Study on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa

    Not recruiting

    2 1 1
    Investigated Diseases:
    Germany
  • Study on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Germany Greece Poland
  • Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Greece Italy +3
  • Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Greece +8